HomeCompareUBAZF vs MRK

UBAZF vs MRK: Dividend Comparison 2026

UBAZF yields 18.10% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 UBAZF wins by $8.2K in total portfolio value
10 years
UBAZF
UBAZF
● Live price
18.10%
Share price
$11.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$64.9K
Annual income
$5,471.74
Full UBAZF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — UBAZF vs MRK

📍 UBAZF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodUBAZFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, UBAZF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
UBAZF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

UBAZF
Annual income on $10K today (after 15% tax)
$1,538.46/yr
After 10yr DRIP, annual income (after tax)
$4,650.98/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $3,677.43/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of UBAZF + MRK for your $10,000?

UBAZF: 50%MRK: 50%
100% MRK50/50100% UBAZF
Portfolio after 10yr
$60.9K
Annual income
$7,634.94/yr
Blended yield
12.55%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

UBAZF
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

UBAZF buys
0
MRK buys
0
No recent congressional trades found for UBAZF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricUBAZFMRK
Forward yield18.10%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$64.9K$56.8K
Annual income after 10y$5,471.74$9,798.13
Total dividends collected$35.0K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: UBAZF vs MRK ($10,000, DRIP)

YearUBAZF PortfolioUBAZF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$12,510$1,809.95$11,206$366.19+$1.3KUBAZF
2$15,502$2,116.12$12,650$502.35+$2.9KUBAZF
3$19,038$2,450.65$14,407$694.19+$4.6KUBAZF
4$23,183$2,812.73$16,585$967.82+$6.6KUBAZF
5$28,007$3,201.11$19,342$1,363.89+$8.7KUBAZF
6$33,581$3,614.20$22,913$1,947.19+$10.7KUBAZF
7$39,982$4,050.09$27,662$2,823.89+$12.3KUBAZF
8$47,288$4,506.60$34,159$4,173.35+$13.1KUBAZF
9$55,579$4,981.33$43,337$6,308.80+$12.2KUBAZF
10$64,941$5,471.74$56,776$9,798.13+$8.2KUBAZF

UBAZF vs MRK: Complete Analysis 2026

UBAZFStock

Uzabase, Inc. provides information infrastructure to support decision-making in business activities primarily in Japan and internationally. It operates SPEEDA, a business information platform that provides insights for business strategy development and market analysis, including global corporate data, industry reports, market data, M&A deals, and expert insights to financial institutions and general businesses; FORCAS, a B2B marketing platform; and NewsPicks, a social business media that offers economic and business news articles. The company also operates INITIAL, a startup information platform that provides one-stop source to general data, financing, investors, and business partners of startups, as well as articles on related topics; and AlphaDrive, a consulting business that supports corporate clients in relation to new business development, next generation human resource development, and revitalising organizations. In addition, it operates MIMIR, a network business; SPEEDA EDGE, a market intelligent platform that offers industry-driven insights, including emerging tech trends, disruptors, partnership deals, and custom research; and UB VENTURES, a venture capital business that focuses on financing seed to early-stage SaaS and media startups. Uzabase, Inc. was incorporated in 2008 and is headquartered in Tokyo, Japan.

Full UBAZF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this UBAZF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

UBAZF vs SCHDUBAZF vs JEPIUBAZF vs OUBAZF vs KOUBAZF vs MAINUBAZF vs JNJUBAZF vs ABBVUBAZF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.